Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The latest on manufacturing and potential treatments for COVID-19 with news from Moderna, Eli Lilly and Company, AstraZeneca, the World Health Organization, and others. Manufacturing and supply of COVID-19 vaccines and drugs Moderna, EU in Supply...

Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, reported that they have submitted a request to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) of their mRNA vaccine candidate, BNT162b2, against...

Novartis has formed an exclusive worldwide license and collaboration agreement, in a deal worth up to $1.355 billion ($50 million upfront and $1.305 billion in milestones and other payments), with Mesoblast, a Melbourne, Australia-based developer...

Merck & Co has agreed to acquire OncoImmune, a Rockville, Maryland-based clinical-stage biopharmaceutical company with a drug to treat COVID-19 in Phase III development, in a $475-million deal. OncoImmune recently announced positive findings...

Emer Cooke, formerly Director with the World Health Organization, began her new role as Executive Director of the European Medicines Agency (EMA) last week (November 16, 2020). She succeeds Guido Rasi, who completed his second term as Executive...

The latest on manufacturing and potential treatments for COVID-19 with news from Bausch Health, Inovio, the FDA, Bharat Biotech, and the Medicines Patent Pool. Manufacturing and supply of COVID-19 vaccines and drugs Generics Companies in Pact...

Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has reported positive interim efficacy data of its COVID-19 vaccine candidate, mRNA-1273, from a Phase III study, which found the vaccine...

Bristol-Myers Squibb (BMS) has completed its $13.1-billion acquisition of MyoKardia, a Brisbane, California-based clinical-stage biopharmaceutical company focused on cardiovascular diseases. BMS had announced the acquisition last month (October...

Mylan and Pfizer have completed their previously announced combination of Mylan and Upjohn, Pfizer’s off-patent branded and generic established medicines business, to form a new company, Viatris. The companies had announced the merger in July...